Friday, March 29, 2024
News

Study: Type 2 diabetes medication may be used to treat autoimmune disease

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Washington | May 28, 2023 11:09:28 PM IST
A drug often used to treat type 2 diabetes, according to research from Swansea University, may also be used to treat autoimmune diseases.

Academics at the University's Faculty of Medicine, Health and Life Science have found that the drug, canagliflozin (also known as Invokana), could be used to treat autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus as it targets T-cells, which form an essential component of the immune system. Canagliflozin is a drug that controls blood sugar levels in people with type 2 diabetes, however researchers have found an unexpected role for the drug involving the human immune system.

Existing research has reported that targeting T-cell metabolism in autoimmunity can lead to therapeutic benefits. T-cells are a type of white blood cell that help the body fight infections and diseases, but in autoimmune diseases they have been observed to attack healthy tissues.

The new study, funded by the Medical Research Council and published today in the journal Cell Metabolism, found that canagliflozin dampens down T-cell activation, suggesting that the drug could be repurposed as a treatment for T-cell driven autoimmunity.Dr Nick Jones, senior author who led the study said: "Our findings are significant as they provide the foundation for the clinical development of canagliflozin for the treatment of certain autoimmune diseases. As the drug is already widely used and has a known safety profile in humans, it could potentially reach clinic quicker than any new drugs developed and bring valuable benefits more swiftly to patients with autoimmune disorders."

Ben Jenkins, first author and postdoctoral researcher at Swansea said: "Identifying new roles for drugs that are currently being used in other disease settings is an exciting area of research. Given that our research primarily targets the metabolism of immune cells, we hope that the potential therapeutic benefits of our findings are applicable to a wide range of conditions."

The researchers are hopeful that canagliflozin will enter a clinical trial to treat certain autoimmune disorders in the future. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Study finds how childhood sedentariness ...
Longer genes are associated with ageing...
Dr. Dangs Lab aims to revolutionise heal...
Researchers find ways to reduce side eff...
Study gives insight into role of specifi...
Collaborative study between bariatric, t...
More...
 
INDIA WORLD ASIA
'My father was being given slow poison; ...
Chennai: Three dead after false ceiling ...
Jailed gangster-turned-politician Mukhta...
Eknath Shinde's Shiv Sena releases first...
Uttar Pradesh: Security tightened in Ali...
'A closed chapter now...': BJP leader Di...
More...    
 
 Top Stories
Columbia expels Argentina's diploma... 
Bunker demand surges in Sri Lankan ... 
Allu Arjun unveils his wax statue a... 
Elena Rybakina fends off Victoria A... 
Danielle Collins downs Ekaterina Al... 
"Absolutely baseless": Former UP DG... 
Grigor Dimitrov ousts top-seeded Ca... 
Telangana: Fire breaks out at vehic...